-
| Exchange | NASDAQ |
|---|---|
| CurrencyCode | USD |
| ISIN | US68236V3024 |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market Cap | 290M |
|---|---|
| PE Ratio | None |
| Beta | 1.04 |
| Target Price | None |
| Dividend Yield | None |
ETHZilla Corporation operates a technology company focused on Ethereum-based infrastructure for the tokenization of real-world assets. The company develops platforms that enable the conversion of illiquid, institutional-grade assets into blockchain-based financial instruments using Ethereum Layer 2 protocols. It bridges traditional finance and blockchain technology by supporting regulated access, scalability, and efficiency in asset tokenization. The company was formerly known as 180 Life Sciences Corp. and changed its name to ETHZilla Corporation in August 2025. ETHZilla Corporation is headquartered in Palm Beach, Florida.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for ETHZ using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2026